An observational study on the outpatient care of patients with polymyalgia rheumatica in general practice practices within FoPraNet-BW
●Completed
Retrospective observational study

An observational study on the outpatient care of patients with polymyalgia rheumatica in general practice practices within FoPraNet-BW

Acronym: BEBOP PMR

Last updated on 27 October 2026

1 Background

Polymyalgia rheumatica (PMR) is a rheumatic condition that primarily affects older people. Little is known about the prevalence of the condition or the care provided to those affected in Germany. The retrospective observational study „BEBOP PMR“ investigates how patients with PMR are treated in general practitioners’ practices within the FoPraNet-BW network, what symptoms they experience and which doctors they consult.

2 Research question

  • Is it feasible to carry out a retrospective observational study within the FoPraNet-BW research infrastructure?
  • How can the provision of PMR to patients in the FoPraNet-BW research practices be characterised?

3 Study design & methodology

In retrospect, the research teams collected clinical data on patients whom they had treated for PMR in their practices.

4 Recruitment

54 of the study participants are female. The average age at the time of the initial diagnosis of PMR is 70 years. 23 % were treated exclusively at a GP practice, whilst 73 % also consulted other specialist departments (most commonly rheumatology, orthopaedics and neurology). 13 % were admitted to hospital due to PMR.

The most common symptoms include shoulder and hip pain. In addition, 61 % of those affected show signs of an atypical course of the disease, such as fatigue, night sweats or weight loss. Information on laboratory test results at the time of diagnosis cannot be fully determined from the retrospectively analysed healthcare data. 94 % of the participants receive glucocorticoids, often before or at the time of diagnosis. The initial dosage averages 29.5 mg of prednisolone equivalent.

162
Participants
48
practice

5 Study results

The healthcare data analysed show that 54 % of those affected are female. The average age at the time of the initial diagnosis of polymyalgia rheumatica is 70 years. 23 % were treated exclusively at a GP practice, whilst 73 % also consulted other specialist departments, most commonly rheumatology, orthopaedics and neurology. 13 % were admitted to hospital due to PMR.

The most common symptoms include shoulder and hip pain. In addition, 61 % of those affected show signs of an atypical course of the disease, such as fatigue, night sweats or weight loss. Information on laboratory results at the time of diagnosis cannot be fully determined from the retrospectively analysed healthcare data. 94 % of patients are prescribed glucocorticoids, often before or at the time of diagnosis. The initial dosage averages 29.5 mg of prednisolone equivalent.

Consortium leadership

  • Tübingen University Hospital, Institute of General Practice and Interprofessional Care

Principal Investigator

  • Prof. Dr Stefanie Joos

Partner organisations

  • Heidelberg University Hospital, Department of General Practice and Healthcare Research
  • Freiburg University Hospital, Institute of General Medicine
  • Ulm University Hospital, Institute of General Practice
  • Reutlingen University, Reutlingen Research Institute

Course profile

Status
Duration
11/2023 - 02/2024
Type of study
Retrospective observational study
Recruitment
162 participants · 48 practices
Funding reference number
01GK1904A
Course registration